Clinical Trial Update: mFOLFOX/mFOLFIRI vs. mFOLFOX in Advanced or Recurrent Biliary Tract Cancer Second-line [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating mFOLFOX/mFOLFIRI versus mFOLFOX as second-line therapy in advanced or recurrent biliary tract cancer; currently not recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Biliary Cancer Metastatic | Phase 2 | Status: NOT_YET_RECRUITING